Physician profile
Jeffrey S Marrs
NPI 1093795767
$36,372.89
in general payments reported to CMS, 2019-2025
6 companies · $24K in 2025
The $24K reported for 2025 was more than what 92% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2021: $5,449 · 2022: $358 · 2023: $1,154 · 2024: $5,364 · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $22K · Travel and Lodging: $7,007 · Food and Beverage: $1,815.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $21,600.00 |
| Travel and Lodging | $7,006.52 |
| Food and Beverage | $1,814.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $34,330.05 | 2019-2025 | Mako, Insignia, Triathlon |
| Smith+Nephew, INC. | $1,667.79 | 2024 | Real Intelligence, Journey II, Legion Revision |
| Depuy Synthes Sales INC. | $200.79 | 2019-2021 | |
| Aesculap Implant Systems, LLC | $107.87 | 2021 | |
| Abbott Laboratories | $38.10 | 2024-2025 | Proclaim, Eterna |
| Medical Device Business Services, INC. | $28.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Marrs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.